MSMonica Sala-Rabanal

Monica Sala-Rabanal

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article

Previous Organizations / Institutes

The organizations / institutes from the scholar's other articles in the past ten years


Monica Sala-Rabanal has a total of 38 co-authors. Here are the top co-authors by number of shared publications:

  • Colin G. Nichols

    Center for the Investigation of Membrane Excitability Diseases (CIMED), Washington University School of Medicine, Saint Louis, Missouri, USA; Department of Cell Biology and Physiology, Washington University School of Medicine, Saint Louis, Missouri, USA

    4 shared publications
  • Bruce A. Hirayama

    Department of Physiology, David Geffen School of Medicine at UCLA, University of California, Los Angeles, CA, 90095-1571, USA

    2 shared publications
  • Dan C. Li

    From the Department of Cell Biology and Physiology, and the Center for the Investigation of Membrane Excitability Diseases (CIMED), Washington University School of Medicine, St. Louis, Missouri 63110

    2 shared publications
  • Ernest M. Wright

    Department of Physiology, David Geffen School of Medicine at UCLA, Los Angeles, California

    2 shared publications
  • Serguei N. Skatchkov

    Department of Biochemistry, Universidad Central del Caribe, Bayamón, PR 00956, USA

    2 shared publications
  • Thomas John Brett

    Department of Pathology and Immunology, Washington University School of Medicine, St. Louis, MO 63110, USA

    2 shared publications

Latest Publications

  • Open Access

    Modulation of TMEM16B channel activity by the calcium-activated chloride channel regulator 4 (CLCA4) in human cells

    by Monica Sala-Rabanal, Zeynep Yurtsever, Kayla N. Berry, Conor McClenaghan, Alyssa J. Foy, Alex Hanson, Deborah F. Steinberg, Jessica A. Greven, Colin E. Kluender, Jennifer M. Alexander-Brett, et al.


  • Open Access

    Intestinal absorption of glucose in mice as determined by positron emission tomography

    by Monica Sala‐Rabanal, Chiara Ghezzi, Bruce A. Hirayama, Vladimir Kepe, Jie Liu, Jorge R. Barrio, Ernest M. Wright

    Key Points: The goal was to determine the importance of the sodium–glucose cotransporter SGLT1 and the glucose uniporter GLUT2 in intestinal glucose absorption during oral glucose tolerance tests (OGTTs) in mice. Glucose absorption was determined in mice using positron emission tomography and three non‐metabolizable glucose probes: one specific for SGLTs, one specific for GLUTs, and one a substrate for both SGLTs and GLUTs. Absorption was determined in wild‐type, Sglt1−/− and Glut2−/− mice. Gastric emptying was a rate‐limiting step in absorption. SGLT1, but not GLUT2, was important in fast glucose absorption. In the absence of SGLT1 or GLUT2, the oral glucose load delivered to the small intestine was slowly absorbed. Oral phlorizin only inhibited the fast component of glucose absorption, but it contributed to decreasing blood glucose levels by inhibiting renal reabsorption. The current model of intestinal absorption is that SGLT1 is responsible for transport of glucose from the lumen into enterocytes across the brush border membrane, and GLUT2 for the downhill transport from the epithelium into blood across the basolateral membrane. Nevertheless, questions remain about the importance of these transporters in vivo. To address these questions, we have developed a non‐invasive imaging method, positron emission tomography (PET), to monitor intestinal absorption of three non‐metabolized glucose tracers during standard oral glucose tolerance tests (OGTTs) in mice. One tracer is specific for SGLTs (α‐methyl‐4‐[18F]fluoro‐4‐deoxy‐d‐glucopyranoside; Me‐4FDG), one is specific for GLUTs (2‐deoxy‐2‐[18F]fluoro‐d‐glucose; 2‐FDG), and one is a substrate for both SGLTs and GLUTs (4‐deoxy‐4‐[18F]fluoro‐d‐glucose; 4‐FDG). OGTTs were conducted on adult wild‐type, Sglt1−/− and Glut2−/− mice. In conscious mice, OGTTs resulted in the predictable increase in blood glucose that was blocked by phlorizin in both wild‐type and Glut2−/− animals. The blood activity of both Me‐4FDG and 4‐FDG, but not 2‐FDG, accompanied the changes in glucose concentration. PET imaging during OGTTs further shows that: (i) intestinal absorption of the glucose load depends on gastric emptying; (ii) SGLT1 is important for the fast absorption; (iii) GLUT2 is not important in absorption; and (iv) oral phlorizin reduces absorption by SGLT1, but is absorbed and blocks glucose reabsorption in the kidney. We conclude that in standard OGTTs in mice, SGLT1 is essential in fast absorption, GLUT2 does not play a significant role, and in the absence of SGLT1 the total load of glucose is slowly absorbed.


  • Open Access

    Revisiting the physiological roles of SGLTs and GLUTs using positron emission tomography in mice

    by Monica Sala‐Rabanal, Bruce A. Hirayama, Chiara Ghezzi, Jie Liu, Sung‐Cheng Huang, Vladimir Kepe, Hermann Koepsell, Amy Yu, David R. Powell, Bernard Thorens, et al.

    Key points: Glucose transporters are central players in glucose homeostasis. There are two major classes of glucose transporters in the body, the passive facilitative glucose transporters (GLUTs) and the secondary active sodium‐coupled glucose transporters (SGLTs). In the present study, we report the use of a non‐invasive imaging technique, positron emission tomography, in mice aiming to evaluate the role of GLUTs and SGLTs in controlling glucose distribution and utilization. We show that GLUTs are most significant for glucose uptake into the brain and liver, whereas SGLTs are important in glucose recovery in the kidney. This work provides further support for the use of SGLT imaging in the investigation of the role of SGLT transporters in human physiology and diseases such as diabetes and cancer. The importance of sodium‐coupled glucose transporters (SGLTs) and facilitative glucose transporters (GLUTs) in glucose homeostasis was studied in mice using fluorine‐18 labelled glucose molecular imaging probes and non‐invasive positron emission tomography (PET) imaging. The probes were: α‐methyl‐4‐[F‐18]‐fluoro‐4‐deoxy‐d‐glucopyranoside (Me‐4FDG), a substrate for SGLTs; 4‐deoxy‐4‐[F‐18]‐fluoro‐d‐glucose (4‐FDG), a substrate for SGLTs and GLUTs; and 2‐deoxy‐2‐[F‐18]‐fluoro‐d–glucose (2‐FDG), a substrate for GLUTs. These radiolabelled imaging probes were injected i.v. into wild‐type, Sglt1–/–, Sglt2–/– and Glut2–/– mice and their dynamic whole‐body distribution was determined using microPET. The distribution of 2‐FDG was similar to that reported earlier (i.e. it accumulated in the brain, heart, liver and kidney, and was excreted into the urinary bladder). There was little change in the distribution of 2‐FDG in Glut2–/– mice, apart from a reduction in the rate of uptake into liver. The major differences between Me‐4FDG and 2‐FDG were that Me‐4FDG did not enter the brain and was not excreted into the urinary bladder. There was urinary excretion of Me‐4FDG in Sglt1–/– and Sglt2–/– mice. However, Me‐4FDG was not reabsorbed in the kidney in Glut2–/– mice. There were no differences in Me‐4FDG uptake into the heart of wild‐type, Sglt1–/– and Sglt2–/– mice. We conclude that GLUT2 is important in glucose liver transport and reabsorption of glucose in the kidney along with SGLT2 and SGLT1. Complete reabsorption of Me‐4FDG from the glomerular filtrate in wild‐type mice and the absence of reabsorption in the kidney in Glut2–/– mice confirm the importance of GLUT2 in glucose absorption across the proximal tubule.


  • Open Access

    Novel Roles for Chloride Channels, Exchangers, and Regulators in Chronic Inflammatory Airway Diseases

    by Monica Sala-Rabanal, Zeynep Yurtsever, Kayla N Berry, Tom J Brett

    Chloride transport proteins play critical roles in inflammatory airway diseases, contributing to the detrimental aspects of mucus overproduction, mucus secretion, and airway constriction. However, they also play crucial roles in contributing to the innate immune properties of mucus and mucociliary clearance. In this review, we focus on the emerging novel roles for a chloride channel regulator (CLCA1), a calcium‐activated chloride channel (TMEM16A), and two chloride exchangers (SLC26A4/pendrin and SLC26A9) in chronic inflammatory airway diseases.


  • Polyamine Transport by the Polyspecific Organic Cation Transporters OCT1, OCT2, and OCT3

    by Monica Sala-Rabanal, Dan C. Li, Gregory R. Dake, Harley T. Kurata, Mikhail Inyushin, Serguei N. Skatchkov, Colin G. Nichols

    Polyamines are ubiquitous organic cations implicated in many physiological processes. Because they are positively charged at physiological pH, carrier-mediated systems are necessary for effective membrane permeation, but the identity of specific polyamine transporter proteins in eukaryotic cells remains unclear. Polyspecific organic cation transporters (OCTs) interact with many natural and xenobiotic monovalent cations and have been reported to transport dicationic compounds, including the short polyamine putrescine. In this study, we used Xenopus oocytes expressing mammalian OCT1 (SLC22A1), OCT2 (SLC22A2), or OCT3 (SLC22A3) to assess binding and transport of longer-chain polyvalent polyamines. In OCT-expressing oocytes, [3H]MPP+ uptake rates were 15- to 35-fold higher than in noninjected oocytes, whereas those for [3H]spermidine increased more modestly above the background, up to 3-fold. This reflected up to 20-fold lower affinity for spermidine than for MPP+; thus, K0.5 for MPP+ was ∼50 μM in OCT1, ∼170 μM in OCT2, and ∼60 μM in OCT3, whereas for spermidine, K0.5 was ∼1 mM in OCT1, OCT2, and OCT3. Jmax values for MPP+ and spermidine were within the same range, suggesting that both compounds are transported at a similar turnover rate. To gain further insight into OCT substrate specificity, we screened a selection of structural polyamine analogues for effect on [3H]MPP+ uptake. In general, blocking potency increased with overall hydrophobic character, which indicates that, as for monovalent cations, hydrophobicity is a major requirement for recognition in polyvalent OCT substrates and inhibitors. Our results demonstrate that the natural polyamines are low affinity, but relatively high turnover, substrates for OCTs. The identification of OCTs as polyamine transport systems may contribute to further understanding of the mechanisms involved in polyamine homeostasis and aid in the design of polyamine-like OCT-targeted drugs.


  • Open Access

    Molecular Mechanisms of EAST/SeSAME Syndrome Mutations in Kir4.1 (KCNJ10)

    by Monica Sala-Rabanal, Lilia Y. Kucheryavykh, Serguei N. Skatchkov, Misty J. Eaton, Colin G. Nichols


  • Serine Side Chain-Linked Peptidomimetic Conjugates of Cyclic HPMPC and HPMPA: Synthesis and Interaction with hPEPT1

    by Larryn W. Peterson, Monica Sala-Rabanal, Ivan S. Krylov, Michaela Serpi, Boris A. Kashemirov, Charles E. McKenna

    Cidofovir (HPMPC), a broad spectrum antiviral agent, cannot be administered orally due to ionization of its phosphonic acid group at physiological pH. One prodrug approach involves conversion to the cyclic form (cHPMPC, 1) and esterification by the side chain hydroxyl group of a peptidomimetic serine. Transport studies in a rat model have shown enhanced levels of total cidofovir species in the plasma after oral dosing with l-Val-l-Ser-OMe cHPMPC, 2a. To explore the possibility that 2a and its three l/d stereoisomers 2b−d undergo active transport mediated by the peptide-specific intestinal transporter PEPT1, we performed radiotracer uptake and electrophysiology experiments applying the two-electrode voltage clamp technique in Xenopus laevis oocytes overexpressing human PEPT1 (hPEPT1, SLC15A1). 2a−d did not induce inward currents, indicating that they are not transported, but the stereoisomers with an l-configuration at the N-terminal valine (2a and 2b) potently inhibited transport of the hPEPT1 substrate glycylsarcosine (Gly-Sar). A “reversed” dipeptide conjugate, l-Ser-l-Ala-OiPr cHPMPC (4), also did not exhibit detectable transport, but completely abolished the Gly-Sar signal, suggesting that affinity of the transporter for these prodrugs is not impaired by a proximate linkage to the drug in the N-terminal amino acid of the dipeptide. Single amino acid conjugates of cHPMPC (3a and 3b) or cHPMPA (5, 6a and 6b) were not transported and only weakly inhibited Gly-Sar transport. The known hPEPT1 prodrug substrate valacyclovir (7) and its l-Val-l-Val dipeptide analogue (8) were used to verify coupled transport by the oocyte model. The results indicate that the previously observed enhanced oral bioavailability of 2a relative to the parent drug is unlikely to be due to active transport by hPEPT1. Syntheses of the novel compounds 2b−d and 3−6 are described, including a convenient solid-phase method to prepare 5, 6a and 6b.